Furthermore, dapagliflozin improved fasting and 2 h plasma glucose levels, fasting insulin concentrations, and insulin sensitivity as measured by homeostasis-model-assessment-estimated insulin resistance (HOMA-IR), none of these effects being observed in the omega 3 or placebo groups [39]. Here, INS is linked to Insulin resistance.